India, May 2 -- A pharma-chemical stock is drawing attention as a long-stagnant manufacturing business looks to enter a stronger growth phase through new API expansion plans. The company has built global scale in Ibuprofen, but its next phase depends on whether it can reduce dependence on one product and successfully expand its broader pharmaceutical ingredient portfolio.

Shares of IOL Chemicals and Pharmaceuticals Ltd closed at around Rs. 94.2, with a market capitalization of around Rs. 2,765 crore. Another notable point is that promoter holding increased from 52.62 percent in December to 57.48 percent in March 2026, indicating higher promoter ownership in the company. The key question now is simple: is this a genuine transition story...